Clinical case of long-term use of durvalumab in the treatment of advanced small-cell lung cancer
Over the last few decades there was a little progress in the treatment of small cell lung cancer (SCLC). But now the approaches are changing with immune checkpoint inhibitors coming into clinical practice. Using a combination of immunotherapy with the standard chemotherapy in the first line of exten...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | article |
| Language: | RU |
| Published: |
IP Habib O.N.
2020
|
| Subjects: | |
| Online Access: | https://doaj.org/article/8d48bbd873984fc38fbcc51025018cde |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|